aluates Reports

$ 0.0

Automative

Global Complement Drug for Blood Disease Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-35G14298

Global Complement Drug for Blood Disease Market Research Report 2023

BUY CHAPTERS

Global Complement Drug for Blood Disease Market Research Report 2024

Code: QYRE-Auto-35G14298

Report

May 2024

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Apellis

Novartis

Roche

Regeneron

Amgen Inc

Samsung Bioepis

Alnylam

Akari Therapeutics

UCB

Amyndas

Complement Drug for Blood Disease Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Complement Drug for Blood Disease Market

The global Complement Drug for Blood Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Complement Drug for Blood Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug for Blood Disease.

Report Scope

The Complement Drug for Blood Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Complement Drug for Blood Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Complement Drug for Blood Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Complement Drug for Blood Disease Market Report

Report Metric	Details
Report Name	Complement Drug for Blood Disease Market
CAGR	5%
Segment by Type	Peptides Antibodies Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amyndas, Apellis, Novartis, Roche, Regeneron, Amgen, Samsung Bioepis, Alnylam, Akari Therapeutics, UCB
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Drug for Blood Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Complement Drug for Blood Disease Market report?

Ans: The main players in the Complement Drug for Blood Disease Market are Amyndas, Apellis, Novartis, Roche, Regeneron, Amgen, Samsung Bioepis, Alnylam, Akari Therapeutics, UCB

What are the Application segmentation covered in the Complement Drug for Blood Disease Market report?

Ans: The Applications covered in the Complement Drug for Blood Disease Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Complement Drug for Blood Disease Market report?

Ans: The Types covered in the Complement Drug for Blood Disease Market report are Peptides, Antibodies, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Complement Drug for Blood Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Peptides

1.2.3 Antibodies

1.2.4 Others

1.3 Market by Application

1.3.1 Global Complement Drug for Blood Disease Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Complement Drug for Blood Disease Market Perspective (2019-2030)

2.2 Complement Drug for Blood Disease Growth Trends by Region

2.2.1 Global Complement Drug for Blood Disease Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Complement Drug for Blood Disease Historic Market Size by Region (2019-2024)

2.2.3 Complement Drug for Blood Disease Forecasted Market Size by Region (2025-2030)

2.3 Complement Drug for Blood Disease Market Dynamics

2.3.1 Complement Drug for Blood Disease Industry Trends

2.3.2 Complement Drug for Blood Disease Market Drivers

2.3.3 Complement Drug for Blood Disease Market Challenges

2.3.4 Complement Drug for Blood Disease Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Complement Drug for Blood Disease Players by Revenue

3.1.1 Global Top Complement Drug for Blood Disease Players by Revenue (2019-2024)

3.1.2 Global Complement Drug for Blood Disease Revenue Market Share by Players (2019-2024)

3.2 Global Complement Drug for Blood Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Complement Drug for Blood Disease Revenue

3.4 Global Complement Drug for Blood Disease Market Concentration Ratio

3.4.1 Global Complement Drug for Blood Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Complement Drug for Blood Disease Revenue in 2023

3.5 Complement Drug for Blood Disease Key Players Head office and Area Served

3.6 Key Players Complement Drug for Blood Disease Product Solution and Service

3.7 Date of Enter into Complement Drug for Blood Disease Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Complement Drug for Blood Disease Breakdown Data by Type

4.1 Global Complement Drug for Blood Disease Historic Market Size by Type (2019-2024)

4.2 Global Complement Drug for Blood Disease Forecasted Market Size by Type (2025-2030)

5 Complement Drug for Blood Disease Breakdown Data by Application

5.1 Global Complement Drug for Blood Disease Historic Market Size by Application (2019-2024)

5.2 Global Complement Drug for Blood Disease Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Complement Drug for Blood Disease Market Size (2019-2030)

6.2 North America Complement Drug for Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Complement Drug for Blood Disease Market Size by Country (2019-2024)

6.4 North America Complement Drug for Blood Disease Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Complement Drug for Blood Disease Market Size (2019-2030)

7.2 Europe Complement Drug for Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Complement Drug for Blood Disease Market Size by Country (2019-2024)

7.4 Europe Complement Drug for Blood Disease Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Complement Drug for Blood Disease Market Size (2019-2030)

8.2 Asia-Pacific Complement Drug for Blood Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Complement Drug for Blood Disease Market Size by Region (2019-2024)

8.4 Asia-Pacific Complement Drug for Blood Disease Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Complement Drug for Blood Disease Market Size (2019-2030)

9.2 Latin America Complement Drug for Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Complement Drug for Blood Disease Market Size by Country (2019-2024)

9.4 Latin America Complement Drug for Blood Disease Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Complement Drug for Blood Disease Market Size (2019-2030)

10.2 Middle East & Africa Complement Drug for Blood Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Complement Drug for Blood Disease Market Size by Country (2019-2024)

10.4 Middle East & Africa Complement Drug for Blood Disease Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amyndas

11.1.1 Amyndas Company Detail

11.1.2 Amyndas Business Overview

11.1.3 Amyndas Complement Drug for Blood Disease Introduction

11.1.4 Amyndas Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.1.5 Amyndas Recent Development

11.2 Apellis

11.2.1 Apellis Company Detail

11.2.2 Apellis Business Overview

11.2.3 Apellis Complement Drug for Blood Disease Introduction

11.2.4 Apellis Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.2.5 Apellis Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Complement Drug for Blood Disease Introduction

11.3.4 Novartis Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Complement Drug for Blood Disease Introduction

11.4.4 Roche Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.4.5 Roche Recent Development

11.5 Regeneron

11.5.1 Regeneron Company Detail

11.5.2 Regeneron Business Overview

11.5.3 Regeneron Complement Drug for Blood Disease Introduction

11.5.4 Regeneron Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.5.5 Regeneron Recent Development

11.6 Amgen

11.6.1 Amgen Company Detail

11.6.2 Amgen Business Overview

11.6.3 Amgen Complement Drug for Blood Disease Introduction

11.6.4 Amgen Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.6.5 Amgen Recent Development

11.7 Samsung Bioepis

11.7.1 Samsung Bioepis Company Detail

11.7.2 Samsung Bioepis Business Overview

11.7.3 Samsung Bioepis Complement Drug for Blood Disease Introduction

11.7.4 Samsung Bioepis Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.7.5 Samsung Bioepis Recent Development

11.8 Alnylam

11.8.1 Alnylam Company Detail

11.8.2 Alnylam Business Overview

11.8.3 Alnylam Complement Drug for Blood Disease Introduction

11.8.4 Alnylam Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.8.5 Alnylam Recent Development

11.9 Akari Therapeutics

11.9.1 Akari Therapeutics Company Detail

11.9.2 Akari Therapeutics Business Overview

11.9.3 Akari Therapeutics Complement Drug for Blood Disease Introduction

11.9.4 Akari Therapeutics Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.9.5 Akari Therapeutics Recent Development

11.10 UCB

11.10.1 UCB Company Detail

11.10.2 UCB Business Overview

11.10.3 UCB Complement Drug for Blood Disease Introduction

11.10.4 UCB Revenue in Complement Drug for Blood Disease Business (2019-2024)

11.10.5 UCB Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Apellis

Novartis

Roche

Regeneron

Amgen Inc

Samsung Bioepis

Alnylam

Akari Therapeutics

UCB

Amyndas

List of Tables

Table 1. Global Complement Drug for Blood Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Peptides

Table 3. Key Players of Antibodies

Table 4. Key Players of Others

Table 5. Global Complement Drug for Blood Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Complement Drug for Blood Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Complement Drug for Blood Disease Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Complement Drug for Blood Disease Market Share by Region (2019-2024)

Table 9. Global Complement Drug for Blood Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Complement Drug for Blood Disease Market Share by Region (2025-2030)

Table 11. Complement Drug for Blood Disease Market Trends

Table 12. Complement Drug for Blood Disease Market Drivers

Table 13. Complement Drug for Blood Disease Market Challenges

Table 14. Complement Drug for Blood Disease Market Restraints

Table 15. Global Complement Drug for Blood Disease Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Complement Drug for Blood Disease Market Share by Players (2019-2024)

Table 17. Global Top Complement Drug for Blood Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug for Blood Disease as of 2023)

Table 18. Ranking of Global Top Complement Drug for Blood Disease Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Complement Drug for Blood Disease Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Complement Drug for Blood Disease Product Solution and Service

Table 22. Date of Enter into Complement Drug for Blood Disease Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Complement Drug for Blood Disease Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Complement Drug for Blood Disease Revenue Market Share by Type (2019-2024)

Table 26. Global Complement Drug for Blood Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Complement Drug for Blood Disease Revenue Market Share by Type (2025-2030)

Table 28. Global Complement Drug for Blood Disease Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Complement Drug for Blood Disease Revenue Market Share by Application (2019-2024)

Table 30. Global Complement Drug for Blood Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Complement Drug for Blood Disease Revenue Market Share by Application (2025-2030)

Table 32. North America Complement Drug for Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Complement Drug for Blood Disease Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Complement Drug for Blood Disease Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Complement Drug for Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Complement Drug for Blood Disease Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Complement Drug for Blood Disease Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Complement Drug for Blood Disease Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Complement Drug for Blood Disease Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Complement Drug for Blood Disease Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Complement Drug for Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Complement Drug for Blood Disease Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Complement Drug for Blood Disease Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Complement Drug for Blood Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Complement Drug for Blood Disease Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Complement Drug for Blood Disease Market Size by Country (2025-2030) & (US$ Million)

Table 47. Amyndas Company Detail

Table 48. Amyndas Business Overview

Table 49. Amyndas Complement Drug for Blood Disease Product

Table 50. Amyndas Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 51. Amyndas Recent Development

Table 52. Apellis Company Detail

Table 53. Apellis Business Overview

Table 54. Apellis Complement Drug for Blood Disease Product

Table 55. Apellis Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 56. Apellis Recent Development

Table 57. Novartis Company Detail

Table 58. Novartis Business Overview

Table 59. Novartis Complement Drug for Blood Disease Product

Table 60. Novartis Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 61. Novartis Recent Development

Table 62. Roche Company Detail

Table 63. Roche Business Overview

Table 64. Roche Complement Drug for Blood Disease Product

Table 65. Roche Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 66. Roche Recent Development

Table 67. Regeneron Company Detail

Table 68. Regeneron Business Overview

Table 69. Regeneron Complement Drug for Blood Disease Product

Table 70. Regeneron Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 71. Regeneron Recent Development

Table 72. Amgen Company Detail

Table 73. Amgen Business Overview

Table 74. Amgen Complement Drug for Blood Disease Product

Table 75. Amgen Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 76. Amgen Recent Development

Table 77. Samsung Bioepis Company Detail

Table 78. Samsung Bioepis Business Overview

Table 79. Samsung Bioepis Complement Drug for Blood Disease Product

Table 80. Samsung Bioepis Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 81. Samsung Bioepis Recent Development

Table 82. Alnylam Company Detail

Table 83. Alnylam Business Overview

Table 84. Alnylam Complement Drug for Blood Disease Product

Table 85. Alnylam Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 86. Alnylam Recent Development

Table 87. Akari Therapeutics Company Detail

Table 88. Akari Therapeutics Business Overview

Table 89. Akari Therapeutics Complement Drug for Blood Disease Product

Table 90. Akari Therapeutics Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 91. Akari Therapeutics Recent Development

Table 92. UCB Company Detail

Table 93. UCB Business Overview

Table 94. UCB Complement Drug for Blood Disease Product

Table 95. UCB Revenue in Complement Drug for Blood Disease Business (2019-2024) & (US$ Million)

Table 96. UCB Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Complement Drug for Blood Disease Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Complement Drug for Blood Disease Market Share by Type: 2023 VS 2030

Figure 3. Peptides Features

Figure 4. Antibodies Features

Figure 5. Others Features

Figure 6. Global Complement Drug for Blood Disease Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Complement Drug for Blood Disease Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Complement Drug for Blood Disease Report Years Considered

Figure 12. Global Complement Drug for Blood Disease Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Complement Drug for Blood Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Complement Drug for Blood Disease Market Share by Region: 2023 VS 2030

Figure 15. Global Complement Drug for Blood Disease Market Share by Players in 2023

Figure 16. Global Top Complement Drug for Blood Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug for Blood Disease as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Complement Drug for Blood Disease Revenue in 2023

Figure 18. North America Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Complement Drug for Blood Disease Market Share by Country (2019-2030)

Figure 20. United States Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Complement Drug for Blood Disease Market Share by Country (2019-2030)

Figure 24. Germany Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Complement Drug for Blood Disease Market Share by Region (2019-2030)

Figure 32. China Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Complement Drug for Blood Disease Market Share by Country (2019-2030)

Figure 40. Mexico Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Complement Drug for Blood Disease Market Share by Country (2019-2030)

Figure 44. Turkey Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Complement Drug for Blood Disease Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Amyndas Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 47. Apellis Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 49. Roche Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 50. Regeneron Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 51. Amgen Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 52. Samsung Bioepis Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 53. Alnylam Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 54. Akari Therapeutics Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 55. UCB Revenue Growth Rate in Complement Drug for Blood Disease Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Complement Drug for Kidney Disease Market Research Report 2024

Global Complement Drug Research Services Market Research Report 2025

Blood thinning Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Haemophilia Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemophilia A Drug Market Research Report 2024

Global Anemia Therapeutic Drugs Market Research Report 2024

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Research Report 2025

Sickle Cell Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemoglobinopathies Drugs Market Research Report 2024

Hematological Malignancies Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune Drugs Market Insights Forecast to 2030

Global Next Generation Antibody Drug Market Research Report 2024

Blood Concentration Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anticoagulant Medicine Market Research Report 2025

Global Heparin Drugs Market Research Report 2024

Global Neutropenia Drugs Market Research Report 2025

Cardiovascular Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bleeding Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions